JP2003267863A - 熱ショック蛋白質誘導剤 - Google Patents
熱ショック蛋白質誘導剤Info
- Publication number
- JP2003267863A JP2003267863A JP2002377732A JP2002377732A JP2003267863A JP 2003267863 A JP2003267863 A JP 2003267863A JP 2002377732 A JP2002377732 A JP 2002377732A JP 2002377732 A JP2002377732 A JP 2002377732A JP 2003267863 A JP2003267863 A JP 2003267863A
- Authority
- JP
- Japan
- Prior art keywords
- heat shock
- shock protein
- gga
- heart
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002377732A JP2003267863A (ja) | 2002-01-09 | 2002-12-26 | 熱ショック蛋白質誘導剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002-2835 | 2002-01-09 | ||
| JP2002002835 | 2002-01-09 | ||
| JP2002377732A JP2003267863A (ja) | 2002-01-09 | 2002-12-26 | 熱ショック蛋白質誘導剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003267863A true JP2003267863A (ja) | 2003-09-25 |
| JP2003267863A5 JP2003267863A5 (enExample) | 2005-10-27 |
Family
ID=29217822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002377732A Pending JP2003267863A (ja) | 2002-01-09 | 2002-12-26 | 熱ショック蛋白質誘導剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2003267863A (enExample) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005112744A (ja) * | 2003-10-06 | 2005-04-28 | Nagase Iyakuhin Kk | ユビデカレノン錠 |
| JP2007217365A (ja) * | 2006-02-17 | 2007-08-30 | Eisai R & D Management Co Ltd | ゲラニルゲラニルアセトンを有効成分として含むチャンネル病治療剤 |
| JP2008523055A (ja) * | 2004-12-10 | 2008-07-03 | ゼルニケ ビジネス サポート ビー.ヴィー. | 熱ショックタンパク質(hsp)および上室性不整脈 |
| JP2014185139A (ja) * | 2013-02-19 | 2014-10-02 | Rohto Pharmaceut Co Ltd | 網膜疾患の予防、改善、又は治療用粘膜適用剤 |
-
2002
- 2002-12-26 JP JP2002377732A patent/JP2003267863A/ja active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005112744A (ja) * | 2003-10-06 | 2005-04-28 | Nagase Iyakuhin Kk | ユビデカレノン錠 |
| JP2008523055A (ja) * | 2004-12-10 | 2008-07-03 | ゼルニケ ビジネス サポート ビー.ヴィー. | 熱ショックタンパク質(hsp)および上室性不整脈 |
| JP2007217365A (ja) * | 2006-02-17 | 2007-08-30 | Eisai R & D Management Co Ltd | ゲラニルゲラニルアセトンを有効成分として含むチャンネル病治療剤 |
| JP2014185139A (ja) * | 2013-02-19 | 2014-10-02 | Rohto Pharmaceut Co Ltd | 網膜疾患の予防、改善、又は治療用粘膜適用剤 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101601679B (zh) | 一种烟酰胺单核苷酸的应用 | |
| KR101909433B1 (ko) | 키나제 저해제의 부작용 저감제 | |
| KR20250048602A (ko) | 미토콘드리아 dna 고갈 증후군을 포함하는 불균형 뉴클레오타이드 풀에 의해 야기된 질환에 대한 데옥시뉴클레오타이드 요법 | |
| KR101604212B1 (ko) | Nad를 함유하는 비만 또는 내당능장애의 예방 및 치료용 조성물 | |
| Ernande et al. | Relationship of brown adipose tissue perfusion and function: a study through β2-adrenoreceptor stimulation | |
| US6846845B2 (en) | Heat shock protein inducer | |
| US20210299127A1 (en) | Pharmaceutical composition for preventing or treating nonalcoholic steatohepatitis | |
| JP2020045359A (ja) | サルビノリン組成物およびその使用 | |
| US9125900B2 (en) | Pharmaceutical composition | |
| JP2019034953A (ja) | 体重増加用化合物の長期使用のための組成物と方法 | |
| US10973800B2 (en) | Salvinorin compositions and uses thereof | |
| US6878689B2 (en) | Preventives or remedies for heart failure | |
| US10342852B2 (en) | Methods of reducing blood glucose or triglyceride levels by administration of METRNL protein | |
| US11000505B2 (en) | Salvinorin compositions and uses thereof | |
| Underwood et al. | The influence of endogenous catecholamines on the inhibitory effects of rolipram against early-and late-phase response to antigen in the guinea pig | |
| WO2000066118A1 (fr) | Compositions pour le traitement de l'infarctus cerebral | |
| ES2396468T3 (es) | Composiciones para uso en el tratamiento del síndrome mielodisplástico | |
| WO2021249376A1 (zh) | Tlr4通路抑制剂和/或拮抗剂在制备药物中的用途 | |
| CN105934245B (zh) | 多发性硬化症的治疗剂或预防剂 | |
| Schauvliege et al. | Cardiovascular effects of enoximone in isoflurane anaesthetized ponies | |
| JP6243850B2 (ja) | 抗がん剤による末梢神経障害の予防、治療、または軽減剤 | |
| CN110384705B (zh) | 山楂酸在制备治疗2型糖尿病胰岛细胞损伤药物中的应用 | |
| Li et al. | CFTR potentiation as a therapeutic strategy for pulmonary edema: a proof-of-concept study in pigs | |
| TW202606762A (zh) | 治療t細胞淋巴瘤之組合物及方法 | |
| Hui et al. | Nasal gel-delivered adenosine A1 receptor agonist induces torpor-like hypothermia and improves survival in a hemorrhagic shock model |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050803 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050803 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20060829 |
|
| A521 | Written amendment |
Effective date: 20061003 Free format text: JAPANESE INTERMEDIATE CODE: A523 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090303 |
|
| A521 | Written amendment |
Effective date: 20090501 Free format text: JAPANESE INTERMEDIATE CODE: A523 |
|
| A02 | Decision of refusal |
Effective date: 20090602 Free format text: JAPANESE INTERMEDIATE CODE: A02 |